BUZZ - Vaxcyte shares soar following successful late-stage clinical trial for pneumococcal vaccine
路透社2026/10/05 10:26October 5 – Vaxcyte (PCVX.O) shares surged 26% pre-market to $71.17. Vaxcyte announced that its 31-valent pneumococcal vaccine VAX-31 met all primary endpoints in a late-stage clinical trial, and generated immune responses comparable to or stronger than Pfizer’s Prevnar 20 and Merck’s Capvaxive. The safety and tolerability of the vaccine were similar to existing vaccines. Vaxcyte expects results from two additional late-stage clinical trials in the first half of 2027, and plans to submit a marketing application to the FDA in the first half of 2028. As of the previous trading session’s close, the stock had risen 22.4% year-to-date.
October 5 - ** Vaxcyte (PCVX.O) shares surged 26% in pre-market trading to $71.17
** Vaxcyte stated that its 31-valent pneumonia vaccine VAX-31 met all primary endpoints in a late-stage clinical trial (link) and generated an immune response comparable to or stronger than that of Pfizer's PFE.N Prevnar 20 and Merck's MRK.N Capvaxive
** The safety and tolerability of the vaccine were comparable to existing vaccines
** Vaxcyte expects to obtain results from two additional late-stage clinical trials in the first half of 2027 and plans to submit a marketing application to the FDA in the first half of 2028
** As of the close of the previous trading day, the stock had risen 22.4% year-to-date
(To facilitate non-English speakers, Reuters provides automated translations of its reports into several other languages. Automated translation may be inaccurate or may fail to capture the intended meaning, and Reuters makes no guarantee regarding the accuracy of the translated text. Automated translation is provided solely for the convenience of readers. Reuters accepts no liability for any damages or losses arising from the use of this automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Neighborhood Intelligence prices registered direct offering at $45.5 million
Neighborhood Intelligence set a registered direct offering of 16,485,508 common shares or pre-funded warrants at $2.76 each. Gross proceeds expected at about $45.5 million; closing targeted on or about Oct. 6, 2026. Warrants issued to buy up to 16,123,189 shares at $3.45; exercisable in six months; expire five years later. Highbridge led the deal; management participated, including Marcus Lemonis; CEO to buy shares only without warrants. Net proceeds earmarked to accelerate merger synergies, build inventory, support working capital; at-the-market facility cut to about $75 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neighborhood Intelligence Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005545003) on October 05, 2026, and is solely responsible for the information contained therein.
Chevron names Jeff Gustavson CFO in senior leadership reshuffle
Chevron set senior leadership changes effective Jan. 1, 2027, reshaping strategy, finance, Oil, Products & Gas, New Energies. Mark Nelson shifts from executive vice president of Oil, Products & Gas to lead Strategy and Business Development. Eimear Bonner moves from chief financial officer to president, Oil, Products & Gas. Jeff Gustavson becomes chief financial officer, moving from president of New Energies. Brent Gros takes over New Energies, moving from president of Offshore, adding oversight of Chevron’s AI strategy. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chevron Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005366851) on October 05, 2026, and is solely responsible for the information contained therein.
BUZZ-TeraWulf doubles power capacity at Kentucky data center campus; stock price rises
October 5 - ** Data center developer TeraWulf (WULF.O) saw its shares rise 3.2% to $16 in pre-market trading ** TeraWulf signed a revised agreement with Kentucky Power, a subsidiary of American Electric Power (AEP.O), to increase the contracted power capacity at its Muskie Data Campus in eastern Kentucky from 500 megawatts to 1 gigawatt ** The agreement advances the planned delivery timeline for the campus' second phase, a 500-megawatt project, from 2030 to 2029, subject to approval by the Kentucky Public Utilities Commission and depending on Kentucky Power's construction schedule ** The agreement is expected to provide $100 million in winter electricity bill credits for Kentucky Power’s residential customers, funded by TeraWulf, over the first 10 years of the contract ** As of the last close, the company’s share price had risen 34.8% so far this year.
Euro: Fragmentation fears weigh on EUR – OCBC
Crypto prices
More
